CR20140153A - Método para el tratamiento de un impedimento sensorial-motriz relacionado con el accidente cerebrovascular con el uso de aminopiridinas - Google Patents

Método para el tratamiento de un impedimento sensorial-motriz relacionado con el accidente cerebrovascular con el uso de aminopiridinas

Info

Publication number
CR20140153A
CR20140153A CR20140153A CR20140153A CR20140153A CR 20140153 A CR20140153 A CR 20140153A CR 20140153 A CR20140153 A CR 20140153A CR 20140153 A CR20140153 A CR 20140153A CR 20140153 A CR20140153 A CR 20140153A
Authority
CR
Costa Rica
Prior art keywords
sensory
motor
aminopiridins
impediment
treatment
Prior art date
Application number
CR20140153A
Other languages
English (en)
Inventor
Andrew R Blight
Anthony O Caggiano
Tom J Parry
Jennifer F Iaci
Original Assignee
Acorda Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acorda Therapeutics Inc filed Critical Acorda Therapeutics Inc
Publication of CR20140153A publication Critical patent/CR20140153A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Métodos y composiciones relacionadas con el uso terapéutico de aminopiridinas en pacientes con un impedimento relacionado con un accidente cerebrovascular, en particular, en pacientes con un impedimento sensorial-motriz relacionado con el accidente cereb
CR20140153A 2011-10-04 2014-04-04 Método para el tratamiento de un impedimento sensorial-motriz relacionado con el accidente cerebrovascular con el uso de aminopiridinas CR20140153A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161543150P 2011-10-04 2011-10-04
US201261591833P 2012-01-27 2012-01-27
US201261648695P 2012-05-18 2012-05-18

Publications (1)

Publication Number Publication Date
CR20140153A true CR20140153A (es) 2014-07-04

Family

ID=47143280

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20140153A CR20140153A (es) 2011-10-04 2014-04-04 Método para el tratamiento de un impedimento sensorial-motriz relacionado con el accidente cerebrovascular con el uso de aminopiridinas

Country Status (21)

Country Link
US (2) US20130085167A1 (es)
EP (1) EP2766017B1 (es)
JP (1) JP6134722B2 (es)
KR (1) KR20140084120A (es)
CN (2) CN108451953A (es)
AR (1) AR088764A1 (es)
AU (2) AU2012318719B2 (es)
BR (1) BR112014008082A8 (es)
CA (1) CA2850635A1 (es)
CL (1) CL2014000799A1 (es)
CO (1) CO7061067A2 (es)
CR (1) CR20140153A (es)
EA (1) EA029558B1 (es)
HK (2) HK1201204A1 (es)
IL (1) IL231809B (es)
MX (1) MX354667B (es)
SG (2) SG10201600410SA (es)
TW (1) TWI592156B (es)
UA (1) UA114486C2 (es)
WO (1) WO2013052575A1 (es)
ZA (1) ZA201402432B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016517856A (ja) * 2013-04-15 2016-06-20 アコルダ セラピュティクス，インコーポレイテッド アミノピリジンを使用した、ある種の卒中に関連した感覚運動障害を治療するための方法
US10172842B2 (en) 2015-09-11 2019-01-08 PharmaDax Inc. Sustained release oral dosage form containing dalfampridine
DE102017115701B4 (de) * 2017-07-12 2022-03-03 Lts Lohmann Therapie-Systeme Ag Fampridin-TTS
CN109172573B (zh) * 2018-09-12 2021-01-26 黑龙江中桂制药有限公司 一种口服抗血栓药物及其用途
CN115018836A (zh) * 2022-08-08 2022-09-06 四川大学 一种癫痫病灶自动分割与预测方法、***及设备

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0696575B2 (ja) * 1987-09-17 1994-11-30 三菱化成株式会社 ４−アミノピリジン誘導体及びその酸付加塩
WO1989009600A1 (en) 1988-04-08 1989-10-19 Massachusetts Institute Of Technology Method and composition for treating neurological disorders
IE82916B1 (en) 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases
CA2085785C (en) * 1992-12-18 2005-03-15 Robert R. Hansebout The use of 4-aminopyridine in the treatment of a neurological condition
US5952357A (en) 1993-12-23 1999-09-14 Cornell Research Foundation, Inc. Treating diseases of the anterior horn cells
AU3360000A (en) * 1999-02-09 2000-08-29 Uab Research Foundation Use of 4-amino pyridine for treatment of peripheral neuropathies
FR2791571B1 (fr) * 1999-04-02 2002-10-04 Sod Conseils Rech Applic Association inhibiteur(s) de no synthase et antioxydant(s) metabolique(s)
WO2001072335A2 (en) * 2000-03-28 2001-10-04 Queen's University At Kingston Methods for effecting neuroprotection using a potassium channel modulator
GB0119435D0 (en) * 2001-02-15 2001-10-03 Aventis Pharm Prod Inc Method of treating of demyelinating diseases or conditions
US8007826B2 (en) 2003-12-11 2011-08-30 Acorda Therapeutics, Inc. Sustained release aminopyridine composition
US8354437B2 (en) 2004-04-09 2013-01-15 Acorda Therapeutics, Inc. Method of using sustained release aminopyridine compositions
WO2008092167A2 (en) * 2007-01-26 2008-07-31 Safenet, Inc. Protecting secrets in an untrusted recipient
CA2825810A1 (en) * 2011-01-28 2012-08-02 Acorda Therapeutics, Inc. Use of 4-aminopyridine to treat cerebral palsy

Also Published As

Publication number Publication date
SG10201600410SA (en) 2016-02-26
EA029558B1 (ru) 2018-04-30
JP6134722B2 (ja) 2017-05-24
EP2766017B1 (en) 2020-07-01
MX2014003997A (es) 2014-07-22
CA2850635A1 (en) 2013-04-11
BR112014008082A8 (pt) 2018-01-16
CO7061067A2 (es) 2014-09-19
IL231809A0 (en) 2014-05-28
CN108451953A (zh) 2018-08-28
EA201490562A1 (ru) 2014-08-29
SG11201401248YA (en) 2014-05-29
KR20140084120A (ko) 2014-07-04
AR088764A1 (es) 2014-07-02
ZA201402432B (en) 2020-08-26
CL2014000799A1 (es) 2014-11-03
HK1201204A1 (en) 2015-08-28
JP2014531470A (ja) 2014-11-27
EP2766017A1 (en) 2014-08-20
WO2013052575A1 (en) 2013-04-11
BR112014008082A2 (pt) 2017-07-18
UA114486C2 (uk) 2017-06-26
CN104220072B (zh) 2018-04-17
CN104220072A (zh) 2014-12-17
MX354667B (es) 2018-03-15
NZ623255A (en) 2016-08-26
US20130085167A1 (en) 2013-04-04
US20160067232A1 (en) 2016-03-10
AU2018200114A1 (en) 2018-01-25
IL231809B (en) 2019-06-30
AU2012318719A1 (en) 2014-04-17
TWI592156B (zh) 2017-07-21
AU2012318719B2 (en) 2017-10-19
HK1204965A1 (en) 2015-12-11
TW201321000A (zh) 2013-06-01

Similar Documents

Publication Publication Date Title
AR089993A1 (es) Macrociclos peptidomimeticos
BR112016011983A2 (pt) Painel, painel laminado, arranjo de painel, método para produzir o painel e uso do painel
UY34278A (es) Derivados novedosos de oxazina y su uso en el tratamiento de enfermedades
CL2015003801A1 (es) Formulaciones de anticuerpos y metodos
GT201400147A (es) Pirimidinas y triazinas fusionadas sustituidas y su uso
ECSP15017505A (es) Imidazo[1,2-a]piridincarboxamidas aminosustituidas y su uso
CO6900118A2 (es) Métodos para tratar el cancer por el uso de antagonistas de unión al eje pd-1e inhibidores de mek
GT201400162A (es) Composición y método para el diagnóstico y el tratamiento de las enfermedades asociadas a la degeneración de las neuritas
BR112014010433A2 (pt) método e máquina para produzir uma cápsula de uso único para bebidas e cápsula obtida com o método
ECSP14026138A (es) Uracilos sustituidos bicíclicamente y uso de los mismos
CR20120449A (es) Formas de rifaximina y sus usos
BR112015002091A2 (pt) método para a produção de um polipeptídeo, polipeptídeo, uso de um polipeptídeo e composição
BR112017005314A2 (pt) inibidores de ssao derivados de imidazo[4,5-c]piridina
CO7000778A2 (es) Derivados de pirazolopiridina, su procedimiento de preparación y su uso terapéutico
BR112015002254A2 (pt) método de produção de chapa de aço silício de grão orientado, chapa de aço elétrico de grão orientado e uso do mesmo
BR112015000534A2 (pt) método para a preparação de 2,4-dihidroxibutirato, microrganismo, organismo e uso
SG11201404946SA (en) Acoustic treatment in an unducted area of a geared turbomachine
EP2918363A4 (en) ELECTRODE, ELECTROCHEMICAL MACHINING DEVICE USING THE ELECTRODE, METHOD OF ELECTROCHEMICAL MACHINING, AND WORKPIECE USING THE SAME
UY35652A (es) Bencil-1h-pirazolo[3,4-b]piridinas y su uso
UY34160A (es) Ligandos del receptor trpm8 y su uso en diversos tratamientos
UY34018A (es) Derivados glucósidos y usos de los mismos
CR20140153A (es) Método para el tratamiento de un impedimento sensorial-motriz relacionado con el accidente cerebrovascular con el uso de aminopiridinas
BR112013034055A2 (pt) alcaftadina para uso no tratamento de urticária
BR112014010340A2 (pt) conjunto de duas unidades de tubulação, método para produzir um conjunto de duas unidades de tubulação, e, uso de um conjunto
BR112015022347A2 (pt) composição para vacinação, método para produzir uma composição para vacinação e uso de composição